Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
Clinical trial NCT04666649 · COMPLETED
Trial details
- NCT number
- NCT04666649
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2024-09-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.